Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-35.85	48.50	75.61
Graham Fair Price	155.45	29312.67	11474.95
PEG	-96.34	< 0.005	0.19
Price/Book	2.98	0.32	0.31
Price/Cash Flow	-399.22	-5.30	-1.06
Prices/Earnings	-81.76	4.89	-26.83
Price/Sales	-9.34	2.69	2.97
Price/FCF	-399.22	-5.30	-1.06
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	71.86	0.86	0.50
Operating Margin	33.95	0.61	0.46
ROA	482.43	< 0.005	< 0.005
ROE	< 0.005	0.02	464.68
ROIC	< 0.005	0.01	24.30
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.47	-95.67
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	4.84	0.64	-86.84
EPS QOQ	-1.42	7.07	397.60
FCF QOQ	-2.65	0.78	-70.65
Revenue QOQ	0.10	0.22	111.85
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	48.19	145.32	201.53
Days Sales Outstanding (DSO)	156.56	124.96	-20.18
Inventory Turnover	1.87	0.62	-66.84
Debt/Capitalization	0.80	0.79	-1.06
Quick Ratio	0.86	1.57	83.19
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	44804.38	48163.96	7.50
Cash	32302.45	43463.37	34.55
Capex	-63.00	-36.90	41.44
Free Cash Flow	-13199.30	-2926.88	77.83
Revenue	4725.11	5769.37	22.10
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	< 0.005	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	69.48	44.25	-36.31
Naive Interpretation	Member

06 - Financial Health · Bad

Rating